Urine HPV Testing for Cervical Cancer Screening Among Women Living With HIV in South Africa
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The purpose of this study explores the usefulness of urine samples for cervical cancer screening in human immunodeficiency virus (HIV)-infected women. Cervical cancer occurs when women are infected with the human papillomavirus (HPV), which can cause changes in the cells that lead to cervical precancer and, eventually, cervical cancer if untreated. However, urine HPV testing has not been well validated low- and middle-income country settings, with no data available to guide its use in HIV-infected women.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Potwierdzone zakażenie wirusem HIV-1.
- •Wiek 25 lat lub więcej.
- •Chęć i możliwość wyrażenia pisemnej zgody na udział w badaniu.
✗ Disqualifies
- •Ciąża lub planowanie ciąży w ciągu 90 dni od rozpoczęcia badania.
- •Badanie pod kątem raka szyjki macicy wykonane w ciągu ostatniego roku.
- •Aktywne zakażenie przenoszone drogą płciową (można wziąć udział po wyleczeniu).
- •Usunięcie macicy na drodze operacyjnej.
- •Historia raka szyjki macicy.
Simplified criteria — AI translation
Trial details
- Minimum age
- 25 Years
- Last updated (source)
- July 1, 2026
- Sex
- Female only
Therapies / drugs in trial
Locations (1)
Clinical HIV Research Unit Temba Lethu Wing Helen Joseph Hospital
Westdene, South Africa
Trial contact
Cheryl Hendrickson
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/3/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.